# The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

> **NCT03045471** · — · UNKNOWN · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 50 (estimated)

## Conditions studied

- To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

## Interventions

- **DRUG:** R-EPOCH
- **DRUG:** R-CHOP

## Key facts

- **NCT ID:** NCT03045471
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03045471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03045471, "The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03045471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*